JWM
ABMD

Janiczek Wealth Management’s Abiomed Inc ABMD Stock Holding History

Janiczek Wealth Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-124
Closed -$31K – 1088
2022
Q3 		$31K Buy
124
+16
+15% +$4.32K 0.01% 381
2022
Q2 		$32K Buy
108
+95
+731% +$25.6K 0.01% 386
2022
Q1 		$4K Buy
13
+7
+117% +$2.15K ﹤0.01% 716
2021
Q4 		$2K Sell
6
-3
-33% -$1.01K ﹤0.01% 865
2021
Q3 		$3K Buy
9
+5
+125% +$1.69K ﹤0.01% 786
2021
Q2 		$1K Sell
4
-3
-43% -$920 ﹤0.01% 887
2021
Q1 		$2K Hold
7
– – ﹤0.01% 760
2020
Q4 		$2K Buy
+7
New +$1.94K ﹤0.01% 700

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Janiczek Wealth Management's ABMD Position: Q4 2022 in Review

Janiczek Wealth Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 124 shares — an estimated $31K sold.

Janiczek Wealth Management first reported a position in ABMD in Q4 2020 and held it in 8 quarters. The position peaked at $32K in Q2 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Janiczek Wealth Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Janiczek Wealth Management sold 124 Abiomed Inc shares in Q4 2022, an estimated $31K.
  • Janiczek Wealth Management first reported a position in Abiomed Inc in Q4 2020 and held it in 8 quarters.
  • Janiczek Wealth Management's Abiomed Inc position peaked at $32K in Q2 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Janiczek Wealth Management's 13F filing for Q4 2022, filed 23 Jan 2023.